Waste Management
Compare Stocks
4 / 10Stock Comparison
AQMS vs RCUS vs ALTG vs AGEN
Revenue, margins, valuation, and 5-year total return — side by side.
Biotechnology
Rental & Leasing Services
Biotechnology
AQMS vs RCUS vs ALTG vs AGEN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Waste Management | Biotechnology | Rental & Leasing Services | Biotechnology |
| Market Cap | $17M | $2.50B | $265M | $132M |
| Revenue (TTM) | $0.00 | $236M | $1.82B | $114M |
| Net Income (TTM) | $-23M | $-369M | $-79M | $115K |
| Gross Margin | — | 90.7% | 25.7% | 35.7% |
| Operating Margin | — | -168.6% | 0.9% | -17.7% |
| Forward P/E | — | — | — | 1.8x |
| Total Debt | $592K | $99M | $1.17B | $10M |
| Cash & Equiv. | $11M | $222M | $19M | $3M |
AQMS vs RCUS vs ALTG vs AGEN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Aqua Metals, Inc. (AQMS) | 100 | 3.1 | -96.9% |
| Arcus Biosciences, … (RCUS) | 100 | 79.1 | -20.9% |
| Alta Equipment Grou… (ALTG) | 100 | 121.7 | +21.7% |
| Agenus Inc. (AGEN) | 100 | 5.0 | -95.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AQMS vs RCUS vs ALTG vs AGEN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AQMS is the clearest fit if your priority is quality.
- 1.2% margin vs RCUS's -156.4%
RCUS carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.
- 45.9% 10Y total return vs ALTG's -8.9%
- Lower volatility, beta 1.95, Low D/E 15.7%, current ratio 4.36x
- Beta 1.95, current ratio 4.36x
- Beta 1.95 vs AGEN's 2.72
ALTG is the clearest fit if your priority is dividends.
- 1.1% yield; the other 3 pay no meaningful dividend
AGEN is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.
- Dividend streak 1 yrs, beta 2.72
- Rev growth 10.4%, EPS growth 100.0%, 3Y rev CAGR 5.2%
- 10.4% revenue growth vs RCUS's -4.3%
- 0.1% ROA vs AQMS's -157.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.4% revenue growth vs RCUS's -4.3% | |
| Quality / Margins | 1.2% margin vs RCUS's -156.4% | |
| Stability / Safety | Beta 1.95 vs AGEN's 2.72 | |
| Dividends | 1.1% yield; the other 3 pay no meaningful dividend | |
| Momentum (1Y) | +209.6% vs AQMS's -51.5% | |
| Efficiency (ROA) | 0.1% ROA vs AQMS's -157.5% |
AQMS vs RCUS vs ALTG vs AGEN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
AQMS vs RCUS vs ALTG vs AGEN — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AGEN leads in 3 of 6 categories
RCUS leads 1 • AQMS leads 0 • ALTG leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AGEN leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ALTG and AQMS operate at a comparable scale, with $1.8B and $0 in trailing revenue. AGEN is the more profitable business, keeping 0.1% of every revenue dollar as net income compared to RCUS's -156.4%. On growth, AGEN holds the edge at +27.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $0 | $236M | $1.8B | $114M |
| EBITDAEarnings before interest/tax | -$22M | -$391M | $90M | -$10M |
| Net IncomeAfter-tax profit | -$23M | -$369M | -$79M | $115,000 |
| Free Cash FlowCash after capex | -$11M | -$489M | $63M | -$159M |
| Gross MarginGross profit ÷ Revenue | — | +90.7% | +25.7% | +35.7% |
| Operating MarginEBIT ÷ Revenue | — | -168.6% | +0.9% | -17.7% |
| Net MarginNet income ÷ Revenue | — | -156.4% | -4.3% | +0.1% |
| FCF MarginFCF ÷ Revenue | — | -2.1% | +3.5% | -139.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | -39.3% | -3.0% | +27.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +71.4% | +10.5% | +4.6% | +85.3% |
Valuation Metrics
Evenly matched — AQMS and ALTG and AGEN each lead in 1 of 3 comparable metrics.
Valuation Metrics
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $17M | $2.5B | $265M | $132M |
| Enterprise ValueMkt cap + debt − cash | $7M | $2.4B | $1.4B | $140M |
| Trailing P/EPrice ÷ TTM EPS | -0.34x | -7.54x | -3.20x | -1102.94x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | 1.79x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | — | 27.27x | — |
| Price / SalesMarket cap ÷ Revenue | — | 10.11x | 0.14x | 1.16x |
| Price / BookPrice ÷ Book value/share | 0.52x | 4.22x | — | — |
| Price / FCFMarket cap ÷ FCF | — | — | 7.09x | — |
Profitability & Efficiency
AGEN leads this category, winning 3 of 9 comparable metrics.
Profitability & Efficiency
RCUS delivers a -69.0% return on equity — every $100 of shareholder capital generates $-69 in annual profit, vs $-33 for ALTG. AQMS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to RCUS's 0.16x. On the Piotroski fundamental quality scale (0–9), AGEN scores 6/9 vs RCUS's 0/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -2.5% | -69.0% | -32.5% | — |
| ROA (TTM)Return on assets | -157.5% | -35.3% | -5.7% | +0.1% |
| ROICReturn on invested capital | -166.7% | -64.1% | +1.4% | — |
| ROCEReturn on capital employed | -139.5% | -42.1% | +2.7% | — |
| Piotroski ScoreFundamental quality 0–9 | 3 | 0 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.04x | 0.16x | — | — |
| Net DebtTotal debt minus cash | -$10M | -$123M | $1.2B | $7M |
| Cash & Equiv.Liquid assets | $11M | $222M | $19M | $3M |
| Total DebtShort + long-term debt | $592,000 | $99M | $1.2B | $10M |
| Interest CoverageEBIT ÷ Interest expense | -32.95x | -13.38x | 0.38x | 1.11x |
Total Returns (Dividends Reinvested)
RCUS leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in RCUS five years ago would be worth $8,143 today (with dividends reinvested), compared to $93 for AQMS. Over the past 12 months, RCUS leads with a +209.6% total return vs AQMS's -51.5%. The 3-year compound annual growth rate (CAGR) favors RCUS at 7.7% vs AQMS's -71.6% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -3.6% | +6.5% | +62.8% | +16.1% |
| 1-Year ReturnPast 12 months | -51.5% | +209.6% | +80.5% | +27.1% |
| 3-Year ReturnCumulative with dividends | -97.7% | +24.9% | -35.8% | -88.2% |
| 5-Year ReturnCumulative with dividends | -99.1% | -18.6% | -33.1% | -93.9% |
| 10-Year ReturnCumulative with dividends | -99.7% | +45.9% | -8.9% | -94.3% |
| CAGR (3Y)Annualised 3-year return | -71.6% | +7.7% | -13.8% | -51.0% |
Risk & Volatility
Evenly matched — RCUS and ALTG each lead in 1 of 2 comparable metrics.
Risk & Volatility
RCUS is the less volatile stock with a 1.95 beta — it tends to amplify market swings less than AGEN's 2.72 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALTG currently trades 90.7% from its 52-week high vs AQMS's 13.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.26x | 1.95x | 2.30x | 2.72x |
| 52-Week HighHighest price in past year | $39.40 | $28.72 | $8.99 | $7.34 |
| 52-Week LowLowest price in past year | $3.37 | $7.06 | $4.16 | $2.71 |
| % of 52W HighCurrent price vs 52-week peak | +13.0% | +86.3% | +90.7% | +51.1% |
| RSI (14)Momentum oscillator 0–100 | 71.9 | 60.5 | 69.1 | 48.8 |
| Avg Volume (50D)Average daily shares traded | 43K | 1.2M | 212K | 814K |
Analyst Outlook
AGEN leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: RCUS as "Buy", ALTG as "Buy", AGEN as "Buy". Consensus price targets imply 95.5% upside for AGEN (target: $7) vs 1.2% for ALTG (target: $8). ALTG is the only dividend payer here at 1.12% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $30.00 | $8.25 | $7.33 |
| # AnalystsCovering analysts | — | 18 | 5 | 11 |
| Dividend YieldAnnual dividend ÷ price | — | — | +1.1% | — |
| Dividend StreakConsecutive years of raises | — | — | 0 | 1 |
| Dividend / ShareAnnual DPS | — | — | $0.09 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +2.8% | +0.1% |
AGEN leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). RCUS leads in 1 (Total Returns). 2 tied.
AQMS vs RCUS vs ALTG vs AGEN: Key Questions Answered
9 questions · data-driven answers · updated daily
01Is AQMS or RCUS or ALTG or AGEN a better buy right now?
For growth investors, Agenus Inc.
(AGEN) is the stronger pick with 10. 4% revenue growth year-over-year, versus -4. 3% for Arcus Biosciences, Inc. (RCUS). Analysts rate Arcus Biosciences, Inc. (RCUS) a "Buy" — based on 18 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — AQMS or RCUS or ALTG or AGEN?
Over the past 5 years, Arcus Biosciences, Inc.
(RCUS) delivered a total return of -18. 6%, compared to -99. 1% for Aqua Metals, Inc. (AQMS). Over 10 years, the gap is even starker: RCUS returned +45. 9% versus AQMS's -99. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — AQMS or RCUS or ALTG or AGEN?
By beta (market sensitivity over 5 years), Arcus Biosciences, Inc.
(RCUS) is the lower-risk stock at 1. 95β versus Agenus Inc. 's 2. 72β — meaning AGEN is approximately 39% more volatile than RCUS relative to the S&P 500. On balance sheet safety, Aqua Metals, Inc. (AQMS) carries a lower debt/equity ratio of 4% versus 16% for Arcus Biosciences, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — AQMS or RCUS or ALTG or AGEN?
By revenue growth (latest reported year), Agenus Inc.
(AGEN) is pulling ahead at 10. 4% versus -4. 3% for Arcus Biosciences, Inc. (RCUS). On earnings-per-share growth, the picture is similar: Agenus Inc. grew EPS 100. 0% year-over-year, compared to -30. 1% for Alta Equipment Group Inc.. Over a 3-year CAGR, RCUS leads at 30. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — AQMS or RCUS or ALTG or AGEN?
Agenus Inc.
(AGEN) is the more profitable company, earning 0. 1% net margin versus -142. 9% for Arcus Biosciences, Inc. — meaning it keeps 0. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALTG leads at 1. 3% versus -156. 3% for RCUS. At the gross margin level — before operating expenses — RCUS leads at 96. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is AQMS or RCUS or ALTG or AGEN more undervalued right now?
Analyst consensus price targets imply the most upside for AGEN: 95.
5% to $7. 33.
07Which pays a better dividend — AQMS or RCUS or ALTG or AGEN?
In this comparison, ALTG (1.
1% yield) pays a dividend. AQMS, RCUS, AGEN do not pay a meaningful dividend and should not be held primarily for income.
08Is AQMS or RCUS or ALTG or AGEN better for a retirement portfolio?
For long-horizon retirement investors, Alta Equipment Group Inc.
(ALTG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (1. 1% yield). Aqua Metals, Inc. (AQMS) carries a higher beta of 2. 26 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ALTG: -8. 9%, AQMS: -99. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between AQMS and RCUS and ALTG and AGEN?
These companies operate in different sectors (AQMS (Industrials) and RCUS (Healthcare) and ALTG (Industrials) and AGEN (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
ALTG pays a dividend while AQMS, RCUS, AGEN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.